341 related articles for article (PubMed ID: 27865203)
1. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
2. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
3. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
8. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
9. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
10. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
[TBL] [Abstract][Full Text] [Related]
11. Euterpe oleracea fruit (Açai)-enriched diet suppresses the development of experimental cerebral malaria induced by Plasmodium berghei (ANKA) infection.
Oliveira KRHM; Torres MLM; Kauffmann N; de Azevedo Ataíde BJ; de Souza Franco Mendes N; Dos Anjos LM; Dos Santos Borges R; Bahia CP; Leão LKR; da Conceição Fonseca Passos A; Herculano AM; de Jesus Oliveira Batista E
BMC Complement Med Ther; 2022 Jan; 22(1):11. PubMed ID: 35016657
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
Van den Steen PE; Deroost K; Van Aelst I; Geurts N; Martens E; Struyf S; Nie CQ; Hansen DS; Matthys P; Van Damme J; Opdenakker G
Eur J Immunol; 2008 Apr; 38(4):1082-95. PubMed ID: 18383042
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
14. Beta interferon suppresses the development of experimental cerebral malaria.
Morrell CN; Srivastava K; Swaim A; Lee MT; Chen J; Nagineni C; Hooks JJ; Detrick B
Infect Immun; 2011 Apr; 79(4):1750-8. PubMed ID: 21245265
[TBL] [Abstract][Full Text] [Related]
15. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
16. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
Zhu X; Liu J; Feng Y; Pang W; Qi Z; Jiang Y; Shang H; Cao Y
Exp Parasitol; 2015 Sep; 156():1-11. PubMed ID: 26005191
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
Martins YC; Freeman BD; Akide Ndunge OB; Weiss LM; Tanowitz HB; Desruisseaux MS
Am J Pathol; 2016 Nov; 186(11):2957-2969. PubMed ID: 27640146
[TBL] [Abstract][Full Text] [Related]
18. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.
Alferink J; Specht S; Arends H; Schumak B; Schmidt K; Ruland C; Lundt R; Kemter A; Dlugos A; Kuepper JM; Poppensieker K; Findeiss M; Albayram Ö; Otte DM; Marazzi J; Gertsch J; Förster I; Maier W; Scheu S; Hoerauf A; Zimmer A
J Biol Chem; 2016 Sep; 291(37):19517-31. PubMed ID: 27474745
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
